These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26231467)

  • 1. Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):211-6. PubMed ID: 26231467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of tiotropium in school-age children with moderate-to-severe symptomatic asthma: A systematic review.
    Rodrigo GJ; Neffen H
    Pediatr Allergy Immunol; 2017 Sep; 28(6):573-578. PubMed ID: 28692145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
    Ohta K; Ichinose M; Tohda Y; Engel M; Moroni-Zentgraf P; Kunimitsu S; Sakamoto W; Adachi M
    PLoS One; 2015; 10(4):e0124109. PubMed ID: 25894430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.
    Kerstjens HA; Casale TB; Bleecker ER; Meltzer EO; Pizzichini E; Schmidt O; Engel M; Bour L; Verkleij CB; Moroni-Zentgraf P; Bateman ED
    Lancet Respir Med; 2015 May; 3(5):367-76. PubMed ID: 25682232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Dahl R; Engel M; Dusser D; Halpin D; Kerstjens HAM; Zaremba-Pechmann L; Moroni-Zentgraf P; Busse WW; Bateman ED
    Respir Med; 2016 Sep; 118():102-111. PubMed ID: 27578478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.
    Paggiaro P; Halpin DM; Buhl R; Engel M; Zubek VB; Blahova Z; Moroni-Zentgraf P; Pizzichini E
    J Allergy Clin Immunol Pract; 2016; 4(1):104-13.e2. PubMed ID: 26563670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study.
    Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M
    Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium in children and adolescents with asthma.
    Murphy KR; Chipps BE
    Ann Allergy Asthma Immunol; 2020 Mar; 124(3):267-276.e3. PubMed ID: 31805357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
    Szefler SJ; Murphy K; Harper T; Boner A; Laki I; Engel M; El Azzi G; Moroni-Zentgraf P; Finnigan H; Hamelmann E
    J Allergy Clin Immunol; 2017 Nov; 140(5):1277-1287. PubMed ID: 28189771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial.
    Hamelmann E; Bateman ED; Vogelberg C; Szefler SJ; Vandewalker M; Moroni-Zentgraf P; Avis M; Unseld A; Engel M; Boner AL
    J Allergy Clin Immunol; 2016 Aug; 138(2):441-450.e8. PubMed ID: 26960245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.
    Kerstjens HA; Disse B; Schröder-Babo W; Bantje TA; Gahlemann M; Sigmund R; Engel M; van Noord JA
    J Allergy Clin Immunol; 2011 Aug; 128(2):308-14. PubMed ID: 21636120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis.
    Wang L; Zhou R; Xie X
    J Asthma; 2019 Jan; 56(1):69-78. PubMed ID: 29420077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
    Vrijlandt EJLE; El Azzi G; Vandewalker M; Rupp N; Harper T; Graham L; Szefler SJ; Moroni-Zentgraf P; Sharma A; Vulcu SD; Sigmund R; Chawes B; Engel M; Bisgaard H
    Lancet Respir Med; 2018 Feb; 6(2):127-137. PubMed ID: 29361462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
    Vogelberg C; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Hamelmann E; Engel M; Szefler S
    Respir Res; 2015 Feb; 16(1):20. PubMed ID: 25851298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Asthma and Role of 2.5 µg Tiotropium Respimat
    Mansfield L; Duong-Quy S; Craig T
    Adv Ther; 2019 Oct; 36(10):2587-2599. PubMed ID: 31435830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Kerstjens HA; Moroni-Zentgraf P; Tashkin DP; Dahl R; Paggiaro P; Vandewalker M; Schmidt H; Engel M; Bateman ED
    Respir Med; 2016 Aug; 117():198-206. PubMed ID: 27492532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the addition of tiotropium on airway dimensions in symptomatic asthma.
    Hoshino M; Ohtawa J; Akitsu K
    Allergy Asthma Proc; 2016 Nov; 37(6):147-153. PubMed ID: 27931291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype.
    Szefler SJ; Vogelberg C; Bernstein JA; Goldstein S; Mansfield L; Zaremba-Pechmann L; Engel M; Hamelmann E
    J Allergy Clin Immunol Pract; 2019; 7(7):2286-2295.e4. PubMed ID: 30922990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
    Buhl R; FitzGerald JM; Meltzer EO; de la Hoz A; Sigmund R; Kerstjens HAM; Bleecker ER
    Pulm Pharmacol Ther; 2020 Feb; 60():101881. PubMed ID: 31874283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.